⌘K

Login Start Free

Home/Filings/4/A/0000899243-22-012518

4/A//SEC Filing

LaFrance Norman D. 4/A

Accession 0000899243-22-012518

CIK 0001095981other

View on SEC.gov Company Profile

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 6:59 PM ET

Size

5.8 KB

Accession

0000899243-22-012518

Insider Transaction Report

Form 4/AAmended

Period: 2021-11-11

PLUS THERAPEUTICS, INC.PSTV

LaFrance Norman D.

CHIEF MEDICAL OFFICER

Transactions

Award
Stock Option (right to buy shares of common stock)
2021-11-11+120,000→ 120,000 total
Exercise: $1.71Exp: 2031-11-11→ Common Stock (120,000 underlying)

Footnotes (1)

[F1]25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments.

Documents

1 file

4
doc4a.xml
FORM 4/A SUBMISSION

Issuer

PLUS THERAPEUTICS, INC.

CIK 0001095981

Entity typeother

Related Parties

1

filerCIK 0001397768

Filing Metadata

Form type: 4/A
Filed: Mar 27, 8:00 PM ET
Accepted: Mar 28, 6:59 PM ET
Size: 5.8 KB

View on SEC.gov